Grade Standard
Medicine Grade
Type
Chemical Reagent
State
Solid
Volatile
Not Volatile
Products Name
PNC-27
Shelf Life
1 Years
Storage Condition
Normal
Colour
Powder
Sample
Available
Standaed
GMP
Assay
>99%
CAS
9104 63-68-2
Melting Point
89°c
Specific Rotation
25D -256°
Delivery
5-8 Days
Boiling Point
574.5±50.0 °c(Predicted)
Mf
C187h291n45o59
Merck
14, 8090
Kpa
13.63±0.46
Transport Package
Carton
Specification
10g/BOTTLE
Trademark
Jinan Andechem
Origin
Jinan
HS Code
29309090
Production Capacity
5000kg/Month
Description:
01.Sommarlutide is a long-acting formulation based on the basic
structure of Liraglutide, which is more effective in the treatment of
type 2 diabetes..
02.Semeglutide is a GLP-1(7-37) chain with 8-position Aib replacing
Ala, 34-position Arg replacing Lys, and 26-position Lys attached to the
stearic acid fatty chain.
03.Compared with Liraglutide, Semeglutide's fat Chemicalbook chain
is longer and its hydrophobicity is increased, but Semeglutide is
modified with short chain PEG and its hydrophilicity is greatly
enhanced.
04.After PEG modification, it can not only bind to albumin closely,
cover the hydrolysis site of DPP-4 enzyme, but also reduce renal
excretion, prolong biological half-life, and achieve a long cycle
effect.
USD:
Se maglutide (Rybelsus, O zempic, NN9535, OG217SC, NNC 0113-0217) is
a long-acting glucagon-like peptide 1 (GLP-1) analogue and agonist of
the GLP-1 receptor. It has potential therapeutic efficacy for type 2
diabetes mellitus (T2DM).